๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Metastases in carcinoma. Analysis of 1000 autopsied cases

โœ Scribed by Herbert L. Abrams; Robert Spiro; Norman Goldstein

Book ID
102663405
Publisher
John Wiley and Sons
Year
1950
Tongue
English
Weight
809 KB
Volume
3
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis

NE of the most striking and disheartening qualities of cancer is the relentlessness of its spread throughout the organism. At the Montefiore Hospital for Chronic Diseases, the observation was made that widespread metastases were present in a higher percentage of the cases that reached the autopsy table than the literature would lead one to believe. Such organs as spleen, ureter, heart-usually considered rare sites of secondary carcinomaappeared to have been involved not uncommonly. Because there have been few recent comprehensive studies of the metastases of carcinoma, it was thought that a study of the metastases of one-thousand consecutive autopsied cases of carcinoma would be of value.

๐Ÿ“œ SIMILAR VOLUMES

Metastases from carcinoma of mammary gla
Metastases from carcinoma of mammary gland: An autopsy study
โœ Nestor Cifuentes; John W. Pickren ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 628 KB

Information on metastases from carcinoma of the mammary gland in an autopsy study of 707 cases occurring in white women over a 15-year period are presented and tabulated. Multiple primary cancers occurred in 19% of the cases. Of the 137 cases that exhibit more than one neoplastic malignancy, 31 (23

Percutaneous radiofrequency ablation for
Percutaneous radiofrequency ablation for hepatocellular carcinoma : An analysis of 1000 cases
โœ Ryosuke Tateishi; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 119 KB

## Abstract ## BACKGROUND Radiofrequency ablation (RFA) was introduced recently as a therapeutic modality for hepatocellular carcinoma (HCC), an alternative to percutaneous ethanol injection therapy (PEIT), which is coming into use worldwide. Previously reported treatment efficacy and complication